PureTech Health Correlations
| PRTC Stock | USD 19.07 0.07 0.37% |
The current 90-days correlation between PureTech Health PLC and Inhibrx Biosciences, is 0.11 (i.e., Average diversification). The correlation of PureTech Health is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
PureTech Health Correlation With Market
Average diversification
The correlation between PureTech Health PLC and DJI is 0.11 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding PureTech Health PLC and DJI in the same portfolio, assuming nothing else is changed.
Moving together with PureTech Stock
Moving against PureTech Stock
| 0.37 | CLOV | Clover Health Investments | PairCorr |
| 0.36 | TOVX | Theriva Biologics | PairCorr |
| 0.35 | MOLN | Molecular Partners | PairCorr |
| 0.31 | ERNA | Eterna Therapeutics | PairCorr |
Related Correlations Analysis
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between PureTech Stock performing well and PureTech Health Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze PureTech Health's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| CLYM | 3.32 | 0.50 | 0.02 | (0.42) | 3.43 | 7.50 | 20.13 | |||
| GNTA | 2.67 | 0.09 | (0.05) | (0.42) | 3.42 | 4.74 | 29.79 | |||
| INBX | 3.16 | 1.10 | 0.23 | 4.76 | 3.18 | 7.99 | 21.90 | |||
| IVA | 3.08 | (0.06) | (0.06) | (0.02) | 3.57 | 6.78 | 18.33 | |||
| KROS | 1.46 | (0.07) | (0.10) | 0.05 | 2.16 | 3.24 | 9.92 | |||
| SLN | 3.92 | 1.16 | 0.27 | (6.65) | 2.84 | 8.98 | 20.04 | |||
| TARS | 1.90 | (0.33) | 0.00 | (0.28) | 0.00 | 4.03 | 9.00 |
PureTech Health Corporate Management
| Frank Salisbury | Senior Strategy | Profile | |
| Anita JD | Senior Property | Profile | |
| Lauren MBA | Chief Officer | Profile | |
| David Elmaleh | CoFounder Advisor | Profile | |
| Spencer Ball | Executive Resources | Profile | |
| III JD | General Secretary | Profile |